SCHOLAR ROCK HOLDING CORPORATION Current Liabilities
SCHOLAR ROCK HOLDING CORPORATION (SRRK) had Current Liabilities of $72.24 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $72.24M.
- 2026-03-31: Liabilities, Current $59.64M.
- 2025-12-31: Liabilities, Current $55.42M.
- 2025-09-30: Liabilities, Current $61.97M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $72.24M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $59.64M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $55.42M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $61.97M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $50.44M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $37.57M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $46.94M 10-K · filed 2026-03-03 |
| 2024-09-30 | $39.37M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $32.99M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $37.51M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $32.74M 10-K · filed 2025-02-27 |
| 2023-09-30 | $26.73M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $24.27M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $26.21M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $36.39M 10-K · filed 2024-03-19 |
| 2022-09-30 | $33.74M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $40.16M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $33.37M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $64.30M 10-K · filed 2023-03-07 |
| 2021-09-30 | $64.60M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $67.02M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $69.95M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $42.56M 10-K · filed 2022-03-07 |
| 2020-09-30 | $32.87M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $32.57M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $27.10M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $32.81M 10-K · filed 2021-03-09 |
| 2019-09-30 | $32.52M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $32.05M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $34.08M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $31.12M 10-K · filed 2020-03-12 |
| 2018-09-30 | $5.76M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $6.68M 10-Q · filed 2018-08-08 |
| 2017-12-31 | $5.02M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |